No Results
"adcreview.com " seems to be safe and legit
ADC Review, Journal of Antibody-drug Conjugates (ISSN 2327-0152) is an international peer-reviewed publication designed to serve the needs of a diverse community of individuals including academia, life sciences, pharma, research, clinicians and physicians. Along with regulatory affairs, we also cover government authorities and representatives from payers to policy makers.
Traffic rank of adcreview.com, compared to all other sites
↓ 248K+
United States
Website ranking is crucial for evaluating adcreview.com's stats. TopWeb.ai leverages cutting-edge techniques, including data gathering, collection, and analysis from diverse internet resources, to estimate website traffic. Our assessments are based solely on publicly available information, offering valuable insights into potential traffic trends without relying on business owner-provided data. Additionally, we utilize advanced tools like ChatGPT and Gemini API to enhance our evaluation process, ensuring accurate and comprehensive traffic estimations and analysis.
Over the last three months, adcreview.com's global ranking has decreased from 4,417,388 to 4,665,453.
Total Visits
Bounce Rate
Pages per Visit
Avg Visit Duration
Moz metrics are by Moz that predicts how well a specific page will rank.
WOT's security score derives from our partners and community-driven expert reviews
Amazon Alexa Rank provides a broad gauge of a website's online popularity.
The Organic Search section reveals valuable insights, including organic traffic and keywords for in Google's top 100 search results.
Explore alternative, competitive and similar websites to adcreview.com based on traffic, content and site structure.
Creative Biolabs, a leading supplier of recombinant antibodies, develops a wide range of antibodies from therapeutic antibodies and single domain antibodies to bispecific antibodies and intrabodies.
Creativebiolabs alternatives
Target a better now with ImmunoGen, Inc., a biotechnology company focused on the development of antibody-drug conjugate (ADC) technology to treat cancer.
Immunogen alternatives
Immunomedics is committed to be a leading, innovative biopharmaceutical company, dedicated to improving health and quality of life with novel immunotherapeutics for the treatment of cancer, autoimmune and other serious diseases.
Immunomedics alternatives
Seattle Genetics is dedicated to improving patient outcomes with advanced antibody-drug conjugate technology delivering cancer-killing therapy to tumor cells.
Seagen alternatives
Seattlegenetics alternatives
Oncology
Takedaoncology alternatives
World ADC San Diego is the industry’s longest standing and most comprehensive antibody-drug conjugate conference. Attend World ADC to maximize the clinical therapeutic index of your antibody-drug conjugate.
Worldadc-usa alternatives
Cortellis - Clarivate Analytics.
Cortellis alternatives
Unryudo alternatives
BeiGene is a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancer.
Beigene alternatives
Check out some of our popular sites.